BSX — Boston Scientific Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Boston Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-82	1,041	698	1,592	1,846
Depreciation
Deferred Taxes
Non-Cash Items	508	212	761	487	851
Unusual Items
Other Non-Cash Items
Changes in Working Capital	41	-351	-1,006	-771	-462
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,508	1,871	1,526	2,503	3,434
Capital Expenditures	-522	-554	-588	-711	-790
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	111	-1,043	-1,423	-1,863	-4,897
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-411	-1,597	-2,011	-2,574	-5,687
Financing Cash Flow Items	-206	-150	-464	-145	-243
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	293	-95	-548	5	1,814
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,388	173	-1,042	-70	-450